2022 AAN Annual Meeting
posted in Events by Brooke Eger
Impel presented four scientific abstracts as part of the 2022 American Academy of Neurology Annual Meeting, including data from our pivotal Phase 3 STOP-301 trial of Trudhesa® for the acute treatment of migraine.